查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566954

封閉系統藥物轉移裝置市場：按類型、組件和最終用戶分類：2024-2033 年全球機會分析和產業預測

Closed System Drug Transfer Device Market By Type , By Component By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

封閉系統藥物轉移裝置（CSTD）市場

2023年，封閉系統給藥裝置（CSTD）市值為8億美元，預計2024年至2033年複合年成長率為15.7%，到2033年將達到36億美元。

封閉系統藥物轉移裝置（CSTD）是醫療設備。 CSTD 可防止環境中的污染物進入醫療設備和系統，並避免危險化學物質和蒸氣從系統進入外部環境。這些設備對於保護患者和醫護人員免受潛在細胞毒性和致畸劑的侵害至關重要。

隨著癌症和其他慢性病的盛行率不斷增加，CSTD 的採用在大多數醫療機構中已變得至關重要，從而推動了市場的成長。此外，職業安全與健康管理局和美國藥典等多個管理機構的監管執法正在推動對 CSTD 的需求。 CSTD 與自動化和機器人技術的整合是一種趨勢，在藥房和配藥設施中受到廣泛關注，以確保危險化學品的高效處理和使用。

然而，CSTD 與各種尺寸的注射器、管瓶和輸液系統的兼容性相關的技術障礙帶來了故障風險，並阻礙了封閉系統藥物輸送裝置 (CSTD) 市場的開拓。此外，CSTD 的使用需要高熟練度和專門培訓，並且通常是資源集中和勞動力密集型的。這阻礙了市場的成長。相較之下，癌症患者的快速增加預計將為市場提供利潤豐厚的成長機會。到 2040 年，癌症患者數量預計每年增加 3,000 萬，醫院需要使用 CSTD。

按部門審查

封閉系統藥物轉移裝置 (CSTD) 市場按類型、組件、最終用戶和區域進行細分。按類型分類，市場分為膜對膜式和無針式。依成分分為屏障型CSTD和空氣清淨機CSTD。依最終使用者分類，可分為醫院/診所、腫瘤中心等。從區域來看，我們對北美、歐洲、亞太地區和拉丁美洲地區進行了分析。

主要發現

按類型分類，膜到膜細分市場主導封閉系統藥物轉移裝置 (CSTD) 市場。

從最終用戶來看，醫院和診所佔據了很大的佔有率。

按地區分類，北美是封閉系統給藥裝置（CSTD）市場的主要收益來源。

該報告可以客製化。

  • 監管指引
  • 根據客戶興趣新增其他公司簡介
  • 平均售價分析/價格分佈分析
  • 歷史市場資料
  • 贖回場景

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章封閉系統藥物轉移裝置（CSTD）市場：依類型

  • 市場概況
  • 膜對膜
  • 無針

第5章封閉系統藥物轉移裝置（CSTD）市場：依組成部分

  • 市場概況
  • 屏障型CSTD
  • 空氣淨化CSTD

第6章 封閉系統藥物轉移裝置（CSTD）市場：依最終使用者分類

  • 市場概況
  • 醫院和診所
  • 腫瘤中心
  • 其他

第7章 封閉系統給藥裝置（CSTD）市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國封閉系統給藥裝置（CSTD）市場
    • 加拿大封閉系統給藥裝置（CSTD）市場
    • 墨西哥封閉系統藥物轉移裝置（CSTD）市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國封閉系統藥物轉移裝置（CSTD）市場
    • 德國封閉系統藥物轉移裝置（CSTD）市場
    • 義大利封閉系統藥物轉移裝置（CSTD）市場
    • 西班牙封閉系統藥物轉移裝置（CSTD）市場
    • 英國封閉系統藥物轉移裝置（CSTD）市場
    • 其他歐洲國家封閉系統藥物轉移裝置 (CSTD) 市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國封閉系統藥物轉移裝置（CSTD）市場
    • 日本封閉系統藥物轉移裝置（CSTD）市場
    • 印度封閉系統給藥裝置（CSTD）市場
    • 韓國封閉系統藥物轉移裝置（CSTD）市場
    • 澳洲封閉式給藥裝置（CSTD）市場
    • 其他亞太地區封閉式給藥裝置 (CSTD) 市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西封閉系統藥物轉移裝置（CSTD）市場
    • 南非封閉系統藥物轉移裝置（CSTD）市場
    • 沙烏地阿拉伯封閉系統藥物轉移裝置（CSTD）市場
    • 其他拉丁美洲/中東/非洲封閉系統藥物轉移裝置 (CSTD) 市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • B. Braun Holding GmbH And Co. KG
  • Baxter International
  • Becton, Dickinson And Company
  • Caragen Ltd.
  • Corvida Medical
  • Equashield
  • FIMI Opportunity Funds（Simplivia Healthcare）
  • ICU Medical
  • JCB Co Ltd.
  • Yukon Medical
簡介目錄
Product Code: A324072

Closed System Drug Transfer Device (CSTD) Market

The closed system drug transfer device (CSTD) market was valued at $0.8 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 15.7% from 2024 to 2033.

A closed system drug transfer device (CSTD) is a medical equipment which prevents contact between the inner environment of a system and the outer surroundings. CSTD forbids the entry of contaminants from the surroundings into medical equipment or system and prohibits the evasion of hazardous chemicals or vapors from the system to the external environment. These devices are critical for the safety of both patients and the medical professionals working in a hospital setting from probable cytotoxic or teratogenic agents.

With increasing prevalence of cancer and other chronic diseases, the adoption of CSTD is becoming essential in most healthcare settings, hence driving the growth of the market. In addition, implementation of regulatory mandates by several governing bodies such as Occupational Safety and Health Administration and the United States Pharmacopeia is boosting the demand for CSTDs. The integration of CSTDs with automation & robotics is a trend gaining significant prominence in pharmacies and drug preparation facilities to ensure efficient handling and usage of hazardous chemicals.

However, technical hurdles associated with the compatibility of CSTDs with diverse sizes of syringes, drug vials, and infusion systems pose the risk of malfunctions and hamper the development of the closed system drug transfer device (CSTD) market. Moreover, the usage of CSTDs requires high proficiency and specialized training, which is usually resource-intensive and laborious. This hampers the market growth. Contrarily, the exponentially rising cases of cancer are anticipated to present lucrative growth opportunities for the market. The number of cancer cases are expected to increase at the rate of 30 million new cases per year by 2040, thereby necessitating the use of CSTDs in hospitals.

Segment Review

The closed system drug transfer device (CSTD) market is segmented into type, component, end user, and region. On the basis of type, the market is bifurcated into membrane to membrane and needleless. Depending on component, it is divided into barrier type CSTDs and air cleaning CSTDs. As per end user, it is categorized into hospitals & clinics, oncology centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the membrane to membrane segment dominates the closed system drug transfer device (CSTD) market.

As per end user, the hospitals & clinics segment holds a high share of the market.

Region wise, North America is the major revenue generator of the closed system drug transfer device (CSTD) market.

Competition Analysis

The key players operating in the global closed system drug transfer device (CSTD) market include B. Braun Holding GmbH & Co. KG, Baxter International, Becton, Dickinson and Company, Caragen Ltd., Corvida Medical, Equashield, FIMI Opportunity Funds (Simplivia Healthcare), ICU Medical, JCB Co Ltd., and Yukon Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Average Selling Price Analysis / Price Point Analysis
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Component

  • Barrier type CSTDs
  • Air cleaning CSTDs

By End User

  • Hospitals and Clinics
  • Oncology Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

By Type

  • Membrane to membrane
  • Needleless

Key Market Players:

    • B. Braun Holding GmbH & Co. KG
    • Baxter International
    • Becton, Dickinson and Company
    • Caragen Ltd.
    • Corvida Medical
    • Equashield
    • FIMI Opportunity Funds (Simplivia Healthcare)
    • ICU Medical
    • JCB Co Ltd.
    • Yukon Medical

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Membrane To Membrane
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Needleless
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Component
  • 5.2. Barrier Type CSTDs
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Air Cleaning CSTDs
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals And Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Oncology Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Component
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Closed System Drug Transfer Device (CSTD) Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Component
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Closed System Drug Transfer Device (CSTD) Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Component
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Closed System Drug Transfer Device (CSTD) Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Component
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Component
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Closed System Drug Transfer Device (CSTD) Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Component
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Closed System Drug Transfer Device (CSTD) Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Component
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Closed System Drug Transfer Device (CSTD) Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Component
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Closed System Drug Transfer Device (CSTD) Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Component
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Closed System Drug Transfer Device (CSTD) Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Component
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Closed System Drug Transfer Device (CSTD) Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Component
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Component
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Closed System Drug Transfer Device (CSTD) Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Component
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Closed System Drug Transfer Device (CSTD) Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Component
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Closed System Drug Transfer Device (CSTD) Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Component
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Closed System Drug Transfer Device (CSTD) Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Component
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Closed System Drug Transfer Device (CSTD) Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Component
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Closed System Drug Transfer Device (CSTD) Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Component
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Component
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Closed System Drug Transfer Device (CSTD) Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Component
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Closed System Drug Transfer Device (CSTD) Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Component
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Closed System Drug Transfer Device (CSTD) Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Component
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Closed System Drug Transfer Device (CSTD) Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Component
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. B. Braun Holding GmbH And Co. KG
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Baxter International
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Becton, Dickinson And Company
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Caragen Ltd.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Corvida Medical
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Equashield
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. FIMI Opportunity Funds (Simplivia Healthcare)
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. ICU Medical
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. JCB Co Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Yukon Medical
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments